Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 1983 Feb;83(2):233-40.
doi: 10.1378/chest.83.2.233.

The additive antianginal action of oral isosorbide dinitrate in patients receiving propranolol. Magnitude and duration of effect

Clinical Trial

The additive antianginal action of oral isosorbide dinitrate in patients receiving propranolol. Magnitude and duration of effect

M M Bassan et al. Chest. 1983 Feb.

Abstract

Ten men with stable angina not completely relieved by full doses of propranolol (mean, 218 mg daily) were given double-blind, on alternate mornings, a placebo or an oral dose (5 to 30 mg) of isosorbide dinitrate (ISDN) previously titrated to lower sitting systolic blood pressure by 20 mm Hg. Patients had been trained in a protocol which precipitated angina after three to six minutes of bicycle exercise. On test days, with propranolol continued, bicycle exercise was performed until the appearance of angina before ISDN or placebo administration, and hourly thereafter for eight hours. Mean exercise duration was greater one hour after ISDN than after placebo by 182 sec (423 +/- 39 vs 241 +/- 13, p less than 0.001), and a difference of 63 sec was still present at six hours (p less than 0.002). At one hour, ISDN lowered resting systolic blood pressure by 26 mm Hg (from 114 +/- 5 mm Hg to 88 +/- 4 mm Hg; p less than .001) without appreciably changing heart rate. We conclude that ISDN is a very effective and reasonably long-acting antianginal supplement to propranolol.

PubMed Disclaimer

Similar articles

Cited by

  • Combination of nitrates with other antianginal drugs.
    Andersson KE, Hoglund P. Andersson KE, et al. Drugs. 1987;33 Suppl 4:43-8. doi: 10.2165/00003495-198700334-00009. Drugs. 1987. PMID: 3304962 Review.
  • Avoiding nitrate tolerance.
    Cowan JC. Cowan JC. Br J Clin Pharmacol. 1992 Aug;34(2):96-101. doi: 10.1111/j.1365-2125.1992.tb04116.x. Br J Clin Pharmacol. 1992. PMID: 1419477 Free PMC article. Review. No abstract available.

Publication types

LinkOut - more resources